Viatris Earnings miss, Revenue beats In Q1 By Investing.com

Viatris reported on Monday first quarter earnings that missed analysts’ forecasts and revenue that topped expectations.

Viatris announced earnings per share of $-0.86 on revenue of $4.43B. Analysts polled by Investing.com anticipated EPS of $0.799 on revenue of $4.2B.

Viatris shares are down 24.87% from the beginning of the year and are trading at $14.08 , down-from-52-week-high.They are under-performing the S&P 500 which is up 12.69% from the start of the year.

Viatris follows other major Healthcare sector earnings this month

Viatris’s report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.

Pfizer had beat expectations on May 4 with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7759 on revenue of $13.65B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar